Central Glass (4044) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
21 Oct, 2026Executive summary
Nine-month net sales fell 12.7% YoY to ¥105,459 million, operating profit declined 20.1% to ¥8,434 million, and profit attributable to owners of parent fell 26.1% to ¥6,869 million.
Semiconductor gas growth was outweighed by weaker electrolyte and medical product sales and soft glass demand.
Full-year forecasts were revised downward; the ¥170-per-share annual dividend forecast was maintained.
Financial highlights
Nine-month comprehensive income fell 45.8% to ¥6,898 million; earnings per share was ¥277.21 versus ¥375.34 a year earlier.
Gross profit was ¥29,971 million, down from ¥31,306 million year over year.
Profit attributable to owners of parent included a ¥1.8bn loss on sales of shares in subsidiaries and affiliates.
Outlook and guidance
FY2024 forecasts were cut to net sales of ¥145,000 million, operating profit of ¥10,500 million, ordinary profit of ¥11.8bn, and profit attributable to owners of parent of ¥6,500 million.
The profit forecast reduction reflected lower recurring profit and an impairment loss at a European electrolyte manufacturing subsidiary.
Forecast EPS was ¥262.29; the annual dividend forecast remained ¥170 per share, including the ¥85 interim dividend already paid.
Latest events from Central Glass
- New semiconductor materials support a ¥470億 FY2030 sales target.4044
Investor update - Higher H1 sales masked sharp profit declines, prompting lower FY2023 guidance.4044
Q2 2023 - Sales growth was offset by lower operating profit and net income.4044
Q1 2023 - FY2023 beat profit forecasts, but FY2024 earnings are expected to retreat.4044
Q4 2023 - Stronger glass sales could not offset lower chemical earnings and reduced extraordinary income.4044
Q3 2023 - Sales fell 10.7%, but operating profit rose on LCM support; FY guidance was unchanged.4044
Q1 2024 - H1 earnings fell on weaker demand and a share-sale loss; FY guidance was unchanged.4044
Q2 2024 - FY2025 sales edge higher, but operating profit falls amid weak demand and tariffs.4044
Q4 2024 - H1 operating profit fell 47.3% amid electrolyte pressure; FY2025 guidance was cut.4044
Q2 2025